BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2012
View Archived Issues
FANG cancer vaccine evaluated in phase I trial
Read More
JVRS-100 improves H5N1 vaccine immunogenicity
Read More
Novel muscarinic acetylcholine M1 receptor modulators disclosed
Read More
U.S. researchers prepare new vaccines
Read More
Novel protein kinase inhibitors disclosed by SBI Biotech and CrystalGenomics
Read More
NeuroSearch patents novel monoamine neurotransmitter reuptake inhibitors
Read More
Roche presents novel AMPK activators
Read More
University of Illinois forms new start-up company for cancer products
Read More
Medicure to commence SAVI-PCI trial of Aggrastat
Read More
Immune Pharmaceuticals granted funds by Israel's Office of the Chief Scientist
Read More
Study identifies potential biomarkers of Huntington's disease progression
Read More
Transcend-trastuzumab conjugate BT-2111 program advances
Read More
AMAG Pharmaceuticals completes enrollment in Feraheme trial
Read More
New antibodies designed by Novo Nordisk for hemophilia
Read More
Allos Therapeutics requests reexamination of CHMP opinion on Folotyn
Read More
FDA approves first treatment for advanced BCC
Read More
Health Canada accepts CIP-Isotretinoin submission for review
Read More
Jentadueto approved in U.S.
Read More
Servier and Monash University establish GPCR collaboration
Read More
Domain Therapeutics receives award to develop therapeutics for Parkinson's disease
Read More
Orexo ends collaboration with Janssen
Read More
Takeda returns Posidur rights to Durect
Read More
ATS-907 enters clinical development
Read More